Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea

OBJECTIVES: The aim of this study was to characterize the benefits of converting Electronic Medical Records (EMRs) to a common data model (CDM) and to assess the potential of CDM-converted data to rapidly generate insights for benefit-risk assessments in post-market regulatory evaluation and decisio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Hui Xing, Teo, Desmond Chun Hwee, Lee, Dongyun, Kim, Chungsoo, Neo, Jing Wei, Sung, Cynthia, Chahed, Haroun, Ang, Pei San, Tan, Doreen Su Yin, Park, Rae Woong, Dorajoo, Sreemanee Raaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Medical Informatics 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117808/
https://www.ncbi.nlm.nih.gov/pubmed/35576979
http://dx.doi.org/10.4258/hir.2022.28.2.112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117808/
https://www.ncbi.nlm.nih.gov/pubmed/35576979
http://dx.doi.org/10.4258/hir.2022.28.2.112

Ejemplares similares